首页> 外国专利> GUAIANE SESQUITERPENES BASED COMPOUND WITHOUT CELL CYTOTOXICITY SEPARATED FROM LACTARIUS HATSUDAKE EXTRACT, A MANUFACTURING METHOD THEREOF, AND AN ANTIINFLAMMATORY COMPOSITION CONTAINING THE SAME

GUAIANE SESQUITERPENES BASED COMPOUND WITHOUT CELL CYTOTOXICITY SEPARATED FROM LACTARIUS HATSUDAKE EXTRACT, A MANUFACTURING METHOD THEREOF, AND AN ANTIINFLAMMATORY COMPOSITION CONTAINING THE SAME

机译:一种基于瓜型倍半萜的化合物,而没有乳酸杆菌提取物分离出的细胞毒性,其制备方法和包含相同成分的抗炎成分

摘要

PURPOSE: Lactarioline A and B are provided to restrain the generation of interferon-γ which is inflammatory cytokine, and to restrain cytotoxicity.;CONSTITUTION: A lactarioline A compound and a lactarioline B compound is respectively in chemical formula 1 and chemical formula 2. A manufacturing method of chemical formula 1 and chemical formula 2, comprises: a step of extracting Lactarius hatsudake by water, C1-2 lower alcohol, or mixed solvent thereof; a step of obtaining n-hexane fraction of the extract; and a step of obtaining a compound by conducting column chromatography into fractions obtained in the above step.;COPYRIGHT KIPO 2012
机译:目的:提供乳环蛋白碱A和B以抑制干扰素-γ的产生。组成:乳环素A化合物和乳环素B化合物分别在化学式1和化学式2中。化学式1和化学式2的制备方法包括:用水,C1-2低级醇或它们的混合溶剂提取hat草。获得提取物的正己烷馏分的步骤; ;以及通过对上述步骤中获得的馏分进行柱色谱法获得化合物的步骤。; COPYRIGHT KIPO 2012

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号